The Conversation (0)
Island Green Cure Ltd., its shareholders and Valens Groworks Corp. (CNSX:VGW) have jointly agreed to terminate the proposed acquisition by Valens of 80 per cent of IGC.
Island Green Cure Ltd., its shareholders and Valens Groworks Corp. (CSE:VGW) have jointly agreed to terminate the proposed acquisition by Valens of 80 per cent of IGC. Valens is releasing IGC from the restrictions and obligations of the 60-day exclusivity period, and IGC is fully refunding the company’s $30,000 deposit.
Valens is proceeding with the proposed acquisition of Health Canada-licensed cannabis testing lab Supra THC Services Ltd., as well as its own application for a limited partnership (LP) to cultivate and sell medical marijuana pursuant to the access to cannabis for medical purposes regulations as an ancillary application to its anticipated Controlled Drugs and Substances Act dealer’s licence.
Valens continues to engage with LP holders, final-stage applicants, and industry and financial sector participants to further its farm-to-pharma objectives. The company’s vision is to integrate natural health products and specialty cannabis offerings and services to create and maintain sustainable revenue and income streams by providing tailored end-to-end, horizontal solutions geared to the needs of patients and consumers.
About Valens Groworks Corp.
Valens Groworks provides management, consulting, testing and support services to domestic and international licensees. It is also financing the buildout of established operations pursuant to its investments in Arizona.
The company’s wholly owned subsidiary, Valens Agritech Ltd., is a postinspection applicant awaiting the granting of a Controlled Drugs and Substances Act dealer’s licence for the cultivation and processing of marijuana.
Connect with Valens Groworks Corp. (CSNX:VGW) to receive an Investor Presentation.
